Privately, the company's development potential depends on three aspects:
1. Colleagues and leaders of the company, I think Baekje is still very good in this respect. Colleagues are excellent, mostly from famous universities at home and abroad, and the leaders are mostly Dr. Turtle or experienced executives dug up from other big foreign companies. The overall comprehensive quality of colleagues is very high. You can learn a lot in such an environment.
2. The company has advanced software and hardware, advanced laboratory instruments and abundant financial resources. Last year, we also cooperated with Amgen, the world biomedical giant.
3. The company has rich product pipelines, reasonable layout, strong R&D strength and accurate strategic positioning.
Baekje Shenzhou (Beijing) Biotechnology Co., Ltd. was registered in Beijing Administration for Industry and Commerce on 201-24 (registration business and file inquiry are handled in the local industrial and commercial branch). ) registered. The legal representative is Ou, and the company's business scope includes basic medical research and development, clinical medical research and development, pharmaceutical research and development, and new anti-tumor drugs research and development.
On March 8, 2020/kloc-0, Baekje Shenzhou was ranked 12 in the Top 2020 Hurun China Health Private Enterprise 100 with a market value of 83 billion yuan.
Refer to Baidu Encyclopedia for the above content? Baiji Shenzhou (Beijing) Biology Science and Technology Co., Ltd.